Recherche
-
XTEND: Two-Year Results from a Global Observational Study Investigating Proactive Dosing of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration
(Ophthalmology and Therapy. vol. 13, n° 3, pp. 725-738, 2024-03-01)Article de revueLibre accès -
Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence
(The British Journal of Ophthalmology. vol. 105, n° 11, 2021-10-21)Article de revueLibre accès -
Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME Studies
(Ophthalmology Retina. vol. 2, n° 10, pp. 988-996, 2018-10)Article de revueLibre accès -
Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend for Macular Edema in Central Retinal Vein Occlusion: The CENTERA Study
(American Journal of Ophthalmology, 2021-02-06)Article de revueLibre accès -
Effect of Baseline Subretinal Fluid on Treatment Outcomes in VIVID-DME and VISTA-DME Studies
(Ophthalmology Retina. vol. 3, n° 8, pp. 663-669, 2019-08)Article de revueLibre accès -
Retinal microvasculature and incident dementia over 10 years: The Three-City-Alienor cohort
(Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. vol. 15, n° 4, pp. e12480, 2023-10)Article de revueLibre accès -
Impact of Baseline Retinal Nonperfusion and Macular Retinal Capillary Nonperfusion on Outcomes in the COPERNICUS and GALILEO Studies
(Ophthalmology Retina. vol. 3, n° 7, pp. 553-560, 2019-07)Article de revueLibre accès -
Real-world outcomes following 12 months of intravitreal aflibercept monotherapy in patients with diabetic macular edema in France: results from the APOLLON study
(Graefe's Archive for Clinical and Experimental Ophthalmology. vol. 258, n° 3, pp. 521-528, 2020)Article de revueLibre accès -
Increased High-Density Lipoprotein Levels Associated with Age-Related Macular Degeneration: Evidence from the EYE-RISK and European Eye Epidemiology Consortia
(Ophthalmology. vol. 126, n° 3, pp. 393-406, 2019-03)Article de revueLibre accès -
Two-year outcomes of the APOLLON observational study of intravitreal aflibercept monotherapy in France in patients with diabetic macular edema
(Scientific Reports. vol. 12, n° 1, 2022-10-29)Article de revueLibre accès